Kadimastem Kadimastem is a biopharmaceutical company that develops industrial regenerative medicine therapies based on differentiated cells derived from human embryonic stem cells (hESCs). | ARKAY ARKAY is a pharmaceutical company that develops RK-01, an orally-active pancreatic beta-cell-centric combination product that provides sustained glycemic control for patients with Type 2 diabetes. | ||
Founding Date | Founding Date 2017 | Founding Date 2009 | Founding Date 2014 |
Type | Type Private | Type Public | Type Private |
Tags | |||
Locations | Locations Basel, CH HQ | Locations Ness Ziona, IL HQ | Locations Windsor, US HQ |
Employees | Employees 10 | Employees 11 | Employees 1 |
Kadimastem is a biopharmaceutical company that develops industrial regenerative medicine therapies based on differentiated cells derived from human embryonic stem cells (hESCs).
View companyARKAY is a pharmaceutical company that develops RK-01, an orally-active pancreatic beta-cell-centric combination product that provides sustained glycemic control for patients with Type 2 diabetes.
View company